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ABSTRAK
Kejuruteraan tisu merupakan satu bidang perubatan baru yang membolehkan tisu 
manusia dibentuk secara in vitro sebelum pemindahan tisu dilakukan. Sel stem 
mesenkima daripada sum sum tulang (BMSCs) adalah sumber sel yang sesuai 
dalam kejuruteraan tisu tulang rawan, ekoran kebolehannya untuk membentuk 
rawan hialin. Kajian ini telah dijalankan untuk mengkaji potensi BMSCs untuk 
membentuk sel rawan secara in vitro dan in vivo. BMSCs dipencilkan daripada 
kambing dan dibahagikan kepada dua kumpulan; iaitu kumpulan kajian dan 
kumpulan kawalan. Sel di dalam kumpulan kawalan disemai di dalam medium 
yang mengandungi 10% serum anak lembu (FBS). Manakala, sel di dalam kumpulan 
kajian telah dikultur di dalam medium yang diperkaya dengan 1% FBS, 1% ITS, 5 
ng/mL TGF-ß3, 50 ng/mL IGF-1, 40 ng/mL L-proline, 100 nM dexamethasone dan 
50 μg / fosfat. Analisis pembentukan sel rawan telah dijalankan secara in vivo pada 
model mencit gondol atimus. Sel didapati beragregasi di dalam kumpulan kajian 
dan menunjukkan permulaannya kondrogenesis telah berlaku dalam pengkulturan 
sel. Kerangka fibrin yang telah disemai bersama sel yang telah atau tidak diaruh 
disediakan dan ditanamkan di dalam lapisan subkutaneus mencik gondol atimus 
selama 5 minggu. Eksplan tersebut kemudiannya dikeluarkan daripada lokasi 
penempelan untuk pemeriksaan histologi. Berdasarkan pewarnaan Safranin O dan 
pengekspresan GAG, eksplan daripada kumpulan kajian didapati menghasilkan 
matriks rawan pada kadar yang tinggi berbanding eksplan di dalam kumpulan 
kawalan. Hasil kajian ini menunjukkan keberkesanan medium rendah serum yang 
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cartilage repair used mesenchymal 
stem cells (MSCs) to achieve the 
therapeutic purpose (Miljkovic et al. 
2008). MSCs are a good cell source 
to engineered cartilage tissue due to 
their ability to undergo chondrogenic 
differentiation after culture-expansion 
with specific growth factors mix 
(Baksh et al. 2004). MSCs fulfil the 
requirements as appropriate cell 
source that is renewable for cartilage 
mengandungi TGF-ß3 merangsang pembezaan sel stem mesenkima daripada 
sum-sum tulang untuk menjadi sel rawan.
Kata kunci: sum-sum tulang, rawan, kondrogenesis, faktor tumbesaran, medium 
rendah serum, sel stem
ABSTRACT
Tissue engineering has emerged as a new promising field that allow in vitro 
construction of whole transplantable tissue. Recently, bone marrow stem cells 
(BMSCs) fulfil the requirements as appropriate cell source that is renewable for 
cartilage tissue engineering since they were able to form hyaline-like cartilage 
in vitro and in vivo when cultured in media supplemented with specific growth 
factors. This study aimed to examine the potential of BMSCs chondrogenesis in 
vitro and in vivo. BMSCs were isolated from sheep and divided into a test group 
and control group. Control group was cultured in medium supplemented with 
10% fetal bovine serum (FBS). Test group was cultured in medium supplemented 
with 1% FBS, 1% ITS, 5ng/mL TGF-ß3, 50ng/mL IGF-1, 40 ng/mL L-proline, 100 nM 
dexamethasone and 50 μg/mL ascorbic acid-2 phosphate. The experiment was 
carried out on athymic nude mice. Cell aggregates were formed in test group and 
indicated the early chondrogenesis in cell culture. Later, cells-fibrin constructs were 
made and implanted subcutaneously into nude mice for 5 wks, then explanted for 
histological examination and glycosaminoglycans (GAG) quantification. Test group 
constructs showed higher cartilage matrix synthesis as confirmed by Safranin O 
staining and GAG production. These results demonstrated the effectiveness of low 
serum media supplemented with TGF-ß3 in promoting chondrogenesis in BMSCs.
Keywords: bone marrow, cartilage, chondrogenesis, growth factors, low serum media, 
stem cells
INTRODUCTION 
Tissue engineering has emerged as 
a new promising field that allow in 
vitro construction of a transplantable 
tissue. The three main parts required 
to construct an engineered tissue 
are: a scaffold, a suitable cells type 
and the addition of substances like 
growth factors (Kou et al. 2006). 
Recently researches focusing on 
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tissue engineering since they can be 
manipulated in vitro to differentiate 
into chondrocytes and able to form 
hyaline-like cartilage in vitro and in 
vivo when they were cultured in media 
supplemented with specific growth 
factors such as transforming growth 
factor (TGF-ßs) and insulin like growth 
factor (IGF-1) (Magne et al. 2005). 
Chondrogenic differentiation happens 
when MSCs were grown in three-
dimensional culture system, serum-
free medium and with the induction 
from members of the TGF-ß super-
family. In these culture environment, 
MSCs rapidly lose their fibroblastic 
characteristic and start to express a 
group of cartilage-specific extracellular 
matrix genes (Barry et al. 2001). There 
are protocols to differential MSCs into 
chondrogenic cells successfully by 
inducing the expression of cartilage-
specific molecules such as collagen 
type II, SOX9 and aggrecan that known 
to promote cartilage formation (Pelttari 
et al. 2008). In the presence of TGF-ß3 
for differentiation protocol, MSCs 
synthesize cartilage oligomeric matrix 
protein, aggrecan, fibromodulin, 
collagen type II and link protein as the 
main matrix components of the normal 
articular cartilage (Rodeo 2001). MSCs 
can be cultured and differentiated 
along multiple phenotypic pathways 
with specific media containing different 
types of growth factors and substances 
such as transforming growth factor beta 
family (TGF-ßs), insulin-like growth 
factor, dexamethasone and vitamin 
C (Jones et al. 2002).  Moreover, their 
expansion in vitro is easier than primary 
autologous chondrocytes (Miljkovic et 
al. 2008). This is due to MSCs having 
much longer life span compared to 
chondrocytes (Hui et al. 2005). Bone 
marrow-derived stem cells (BMSCs) 
can differentiate into chondrogenic 
cells in various culture conditions 
and TGF-ßs were added to enhance 
chondrogenesis process in many 
culture methods (Coleman et al. 2007). 
The chondrogenic differentiation of 
MSCs can be induced by growth 
factors such as IGF-1 and TGF-ß3. Both 
factors can maintain the phenotype of 
chondrocyte; promote the secretion 
of extracellular matrix and promote 
cartilage matrix macromolecules 
synthesis during chondrogenesis 
(Worster et al. 2001; Indrawattana et al. 
2004; Gelse et al. 2003). In vitro study 
had demonstrated that MSCs can form 
hyaline-like cartilage when cultured in 
medium containing TGF-ß3 (Magne 
et al. 2005). It was reported that IGF-1 
regulated the synthesis of collagen type 
II and aggrecan at the transcription level 
during chondrogenic differentiation 
in rat articular chondrocytes while 
TGF-ß3 is the important factor in the 
initial stages of MSCs chondrogenesis 
(Messei et al. 2000; Mastrogiacomo 
et al. 2001) While addition of another 
factor; basic fibroblast growth factor 
(bFGF) was demonstrated to increase 
the proliferation rate and life span 
of dog, rabbit and human MSCs 
(Mastrogiacomo et al. 2001; Tsutsumi et 
al. 2001). Previous studies had showed 
the mitogenic effect of bFGF in human 
chondrocytes and chondrogenic 
effect when combined with TGF-ß2, 
IGF-1 and insulin-transferrin-
selenium in cartilage regeneration 
(Chua et al. 2005; Chua et al. 2007). 
However, there were few studies if 
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any conducted on combination of 
medium with different growth factors 
on BMSCs chondrogenesis either in 
vitro or in vivo. Thus this study aimed 
to investigate the effect of combination 
medium on marrow stem cells (BMSCs) 
in vitro and in vivo chondrogenesis.
MATERIALS AND METHODS
The study was conducted at the 
Institute of Medical Research and 
Tissue Engineering Centre, Universiti 
Kebangsaan Medical Centre Malaysia 
(UKMMC). All experiments in this 
study were performed in accordance 
with Animal Ethical Committee of 
the Faculty of Medicine, Universiti 
Kebangsaan Malaysia (UKMAEC) 
with approval Number FISIO/2006/
R U S Z Y M A H - A U G U S T / 17 5 -
JANUARY-2009.
 About 10 mL of bone marrow was 
aspirated from iliac crest of healthy 
male sheep (n=5). Sterile bone marrow 
aspiration needle (Jamshidi-Dominica 
Republic) connected to heparinized 20 
mL sterile syringe was inserted into hip 
bone (iliac crest) of sheep. The syringe 
was pulled out slowly to collect the 
bone marrow. 
 Mesenchymal stem cells (MSCs) 
were isolated from the specimen via 
gradient centrifugation (Universal 32 
R, Hettich, Germany) over a Ficoll-
Paque PLUS (GE Healthcare-Sweden) 
layer at 3000 rotations per min 
(r.p.m.) for 30 mins and subsequently 
rinsed twice with phosphate buffered 
saline (PBS; Invitrogen, USA). Cells 
were resuspended in the culture 
medium (Ham’s F12: high glucose 
DMEM-FD 1:1; GIBCO, Rockville, 
MD) supplemented with 10% fetal 
bovine serum (GIBCO), 1X antibiotic-
antimycotic (GIBCO), 1X GlutaMAX-1 
(GIBCO), 1% antibiotic/antimycotic, 
50 μg/ml L-ascorbic acid (SIGMA, St. 
Louise, MO), 0.02 M HEPES buffer 
(GIBCO) and plated into T-75 cm2 
flasks. The cells were incubated at 37oC 
in an incubator containing 5% CO2. 
The culture medium was changed 
every 2 to 3 days. 
 Cell morphology was examined using 
an inverted phase contrast microscope 
(CK40; Olympus, Japan). Upon 95% 
confluence, cells were trypsinized. 
Viability and total cell number were 
determined by manual counting using 
a bright field microscope with the aid 
of the trypan blue exclusion dye and a 
haemocytometer. 
 Adult bone marrow mesenchymal 
stem cells were divided into 2 groups; 
test and control groups (n=6): Five 
million of BMSCs were cultured in 
medium supplemented with 10 % FBS 
alone for 3 wks and constructed and 
implanted subcutaneously in nude 
mice. Test group (n=6):  Five million 
of BMSCs were cultured in medium 
supplemented with 1% antibiotic/
antimycotic, 1% FBS, 1% ITS, 1% 
ascorbic acid, 1% GlutaMAX-1 
(GIBCO), 50ng/mL IGF-1, 5ng/mL 
transforming growth factor beta 3 
(TGF-ß3), 50 μg/mL ascorbic acid-2 
phosphate, 40ng/mL L-proline and 
100nM/mL dexamethasone. Each 
group of the cells were plated into five 
T-75 culture flasks and incubated at 
37�C in an incubator containing 5% 
CO2 with media changed every 2 to 3 
days for 3 wks.
 After 3 wks, the cells from test group 
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and control groups were trypsinized 
and suspended in 0.5 mL of sheep 
plasma. A three dimensional (3D) 
cells-fibrin construct was formed by 
adding 30 μL calcium chloride (CaCl2) 
solution into the mixture. The resulted 
three dimensional constructs were 
maintained in 5mL of the same culture 
medium and incubated overnight at 
37�C in an incubator containing 5% 
CO2. 
 Eighteen healthy athymic nude mice 
were divided into two groups (test and 
control); Mice were anesthetized by 0.1 
ml of mixed xylazine-ketamin1:1/25g 
of body weight. Small incision on the 
dorsum part of the mice was made, 
BMSCs construct was implanted 
subcutaneously. After 5 wks, mice 
were euthanized by overdose of 
anaesthetic drugs. Dorsal skin of nude 
mouse was dissected and BMSCs 
construct was carefully removed 
from surrounding tissues, fixed in 5% 
formaldehyde overnight. Each implant 
was divided into two parts for histology 
examination and glycosaminoglycans 
(GAG) quantification. 
 For histological examination, 
constructs were imbedded in paraffin, 
sectioned into 4 μm thickness and 
stained with Safranin O staining.  GAG 
quantification assay, constructs were 
dried and weighed before treated with 
papain digestive solution (125 μg/
mL of papain, 5 mM L-cystein, 100 
mM Na2HPO4, 100 mM EDTA, pH 
6.8) at 60�C for 16 hours. The GAG 
contents were measured using a 1, 
9 dimethylmethylene blue (DMMB) 
assay. The sample was mixed with 
DMMB solution and the absorbance 
at 590 nm wavelength was measured. 
Total GAG of was determined using 
a standard plot of shark chondroitin 
sulfate (Sigma) and normalized with 
dried-weight of each sample (n=4) as 
the relative GAG content (%).
STATISTICAL ANALYSIS
Statistical analysis, data was expressed 
as mean ± standard error of the mean 
(SEM). Result was analyzed using SPSS, 
Mann-Whitney test and the difference 
were significance when p <0.05. 
RESULTS
The control group of BMSCs cultured 
in medium supplemented with 10% 
FBS demonstrated spindle to polygonal 
cells adhered to the flasks at day 7 in 
culture in passage zero (Figure 1A). The 
cells density increased fast and formed 
pack monolayer cells in the culture at 
day 21 (Figure 1B). However, no cell 
aggregation was detected in this group. 
Interestingly in the test group, BMSCs 
cultured in medium supplemented 
with TGFß-3, IGF-1, ITS and 1% FBS 
exhibited plenty of cell aggregates 
as early as the first week in culture 
(Figure 1C), and the aggregates were 
increased in number and formed big 
cells aggregates at day 14 in culture 
(Figure 1D). 
 Fibrin-cells construct appeared soft, 
shiny and white in colour on the day 
of construction for both groups (test 
and control) before implanted into 
nude mice (Figure 2A). The constructs 
appeared firm and hard on week three 
in the dorsum part of the nude mouse 
(Figure 2B). There was no inflammatory 
response observed around constructs 
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at the implantation site (Figure 2C). 
The removed constructs were white in 
colour and firm in consistency which 
resembled hyaline cartilage when 
harvested at the end of week five 
(Figure 2D). Histological evaluation 
of constructs from control group 
showed no response to Safranin O 
staining (Figure 3A). Interestingly the 
test group was stained positive with 
Safranin O, which denoted abundant 
cartilage matrix production (Figure 
Figure 1: A) Phase-contrast microscopic evaluation on BMSCs culture in media in vitro. Control group; 
BMSCs adhered fast and formed monolayer within 7 days of culture; B) formed dense monolayer 
cells after 3 weeks in culture. C) Test group BMSCs formed early cells aggregates at the first week of 
culture and; D) big cells aggregates can be seen at the end of third week. Magnification x 40.
Figure 2: A) Morphology of cells-fibrin constructs. In vitro construct before implantation; B) Construct 
in the dorsum part of nude mice (arrows); C) Construct at the end week five of implantation, note the 
implant site showed no inflammation response (arrow); D) Explanted construct appeared white and 
hard in consistency when harvest.
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3B
Figure 3: A) Histological evaluation of in vivo BMSCs constructs. Control group showed negative 
staining with safranin O; B) Test group demonstrated positive orange-red staining with Safranin O. 
Magnification x40.
Figure 4: Percentage of area stained positive with Safranin O in the various constructs:  Control 
group: medium supplemented with 10% FBS and the test group: medium supplemented with 1% 
FBS and 10ng/ml TGFβ3.  #Total area stained with Safranin O in the test group was significantly 
higher than control group. Data were presented as mean ± standard error of mean and analyzed 
using Mann-Whitney test.
Figure 5: GAG quantification after 5 wks of implantation. *GAG production level in the test group 
was significantly higher (P < 0.05) compared to GAG production level in control group. Data was 
analyzed using Mann-Whitney test. Data were presented as mean ± standard error of mean of GAG 
production.
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3B). Data analysis showed that 
positive area stained with Safranin O 
was significantly higher in test group 
(scored 75.73 ± 7.68 % of the total 
area stained positive with Safranin O; 
p< 0.05) (Figure 4), when compared 
to control which were weakly stained 
and only scored 2.89 ± 2.84 % of total 
area with Safranin O (Figure 4). Total 
GAGs production was normalized 
in each group by dried weight and 
showed as the relative sGAG content 
in percentage (%) after 5 wks of in vivo 
implantation of cells-fibrin constructs 
in the nude mice. Constructs from the 
test group BMSCs cultured in medium 
supplemented with 1% FBS and 10ng/
mL TGF-ß3 exhibited the highest sGAG 
production and was significant higher 
than control group (P < 0.05; 0.32 ± 
0.014; Figure 5). Control group BMSCs 
cultured in medium supplemented 
with 10% FBS showed the lowest GAG 
production (0.211 ± 0.006; Figure 5). 
DISCUSSION
Previous study showed that human 
bone marrow MSCs can expand to 
large number and encapsulate as 
osteochondral constructs to form 
synovial joint condyles for in vivo 
implantation. MSCs has the ability 
to differentiate into different cell 
lineages such as chondrocytes, 
myoblasts, osteoblasts, adipocytes 
and fibroblasts. Some differentiated 
cells can express the key markers of 
neuron-like cells, endothelial cells 
and cardiomyocytes (Marion & Mao 
2006). A study was conducted by Al 
Faqeh et al. (2012), which showed 
that BMSCs grew in low serum 
medium containing IGF-1, TGF-ß3 
and dexamethasone for 3 wks were 
able to form colonies and aggregates. 
This was in contrast compared to cells 
culture in basic medium that only can 
formed multilayer cells. In this study 
we demonstrated that bone marrow 
mesenchymal stem cells (BMSCs) 
cultured in medium supplemented 
with 1% FBS and TGF-ß3 showed great 
potential in chondrogenesis in vitro. 
Transforming growth factor beta 3 
(TGF-ß3) is needed to stimulate MSCs 
chondrogenesis in the early stages and 
this cause the cells aggregation (Roark 
& Greer 1994). In the monolayer 
culture-expansion, BMSCs changed 
from polygonal shape to spinal-like 
appearance as early as first passage. 
The same result was reported 
previously in human chondrocytes 
that proliferate fast (Ruszymah et al. 
2007). Subsequently, cultured BMSCs 
regardless of culture media used were 
mixed well with sheep plasma. Addition 
of CaCl2 initialled the polymerization 
of fibrin and formation of physically 
stable construct for transplantation. 
 In the present study the 
chondrogenesis of BMSCs in vivo 
was induced successfully after BMSCs 
cultured in medium supplemented 
with 1% FBS and 10ng/mL TGF-ß3. This 
result was supported by histological 
evaluation (Safranin O staining) and 
glycosaminoglycan’s (GAG) assay. 
TGF-ß3 is more chondrogenic efficient 
when added to BMSCs culture to 
induce chondrogenesis.
 The result of this study showed no 
cell aggregation in the control group 
cultured in medium supplemented 
with 10% FBS. In this study the 
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chondrogenesis was induced in high-
density of cells 5 x106 cells/20mL in 
the culture. Numbers of cell aggregates 
was formed as early as day two and 
day three of the culture and the size 
of cell aggregates increased by time 
in test group of BMSCs cultured in 
medium supplemented with 1% 
FBS and 10ng/mL TGF-ß3. This 
phenomenon was not observed in 
the control. These results showed that 
TGF-ß3 possesses great potential to 
induce early chondrogenesis in BMSCs 
in vitro and in vivo. The implanted 
constructs of BMSCs from the test and 
control groups were appeared white 
in color and hard in consistency when 
harvested after 5 wks of implantation. 
Although the constructs from control 
group appeared larger than the test 
group construct, it did not show sign 
of chondrogenesis. The Safranin O 
staining was negative and the level 
of GAG production was the lowest 
compared to the test group. This 
result could contribute by higher 
concentration of FBS in the medium 
promote BMSCs proliferation but 
inhibit GAG production. 
 The test group BMSCs constructs 
showed significant higher GAG 
production when compared with 
the control group (BMSCs only). 
Interestingly the group of BMSCs 
constructs that was supplemented 
with TGF-ß3 showed the highest cell 
aggregates in vitro, highest Safranin O 
stained area with high GAG production 
in vivo. These findings agree with 
the previous study that BMSCs 
differentiation using TGF-ß3 was 10 
times more active than other TGF-ß 
family. The combination of TGF-ß3 
and IGF-1 was more effective to 
induce chondrogenesis (Indrawattana 
et al. 2004). The result of the present 
study suggests that TGF-ß3 should be 
considered as specific growth factor 
to induce BMSCs chondrogenesis. 
The histological evaluation and GAGs 
production of BMSCs construct of 
the test group (BMSCs cultured in 
medium supplemented with 1% FBS 
and TGF-ß3) were clear evidence of 
BMSCs chondrogenesis enhancement. 
Our result suggested that growth factor 
TGF-ß3 and BMSCs in chondrogenesis 
are relevant for developing cartilage 
in future. This has provided a new 
therapeutic alternative for the treatment 
of osteoarthritis (OA) in the joint. 
The lowest quality of chondrogenic 
feature of BMSCs cultured in medium 
supplemented with 10% FBS (control) 
suggested medium with high 
concentration of serum is not desirable 
for chondrogenic induction. 
 Our result was supported by another 
study that showed the chondrogenic 
differentiation of MSCs was stained 
positive for collagen type II antibody 
and the expression of COL2A1 was 
upregulated significantly (Ullah et al. 
2013). Another study showed GAG 
production and collagen type II 
synthesis in MSCs were inhibited in 
high percentage of serum (Bilgen et 
al. 2007). The formation of cartilage 
matrix in vivo could contribute by the 
cell aggregation in the test groups. 
Our results demonstrated that BMSCs 
cultured in medium supplemented 
with TGF-ß3 and 1% FBS induced 
higher chondrogenesis activity in 
BMSCs. In conclusion, bone marrow 
mesenchymal stem cells (BMSCs) 
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cultured in medium supplemented 
with 1% FBS and 10 ng/mL TGF-ß3 
showed chondrogenic capability in 
vitro and in vivo compared to BMSCs 
cultured in medium supplemented 
with 10% FBS. This study suggests 
that TGF-ß3 could enhance BMSCs 
chondrogenesis phenotype in vivo 
and promotes the chondrocyte 
phenotype by enhancing sulfated 
glycosaminoglycans accumulation. 
LIST OF ABBREVIATIONS
BMSC:  bone marrow mesenchymal 
stem cells; TGF:  transforming growth 
factor; DMEM: Dulbecco’s Modified 
Eagle Medium; MSCs: mesenchymal 
stem cells, FBS: Fetal bovine serum; 
PBS: phosphate buffered saline; 
FD: Ham’s F12: DMEM (1:1); GAG: 
Glycosaminoglycan; DMMB: 1, 
9-dimethylmethylene blue; IGF: 
insulin like growth factor; ITS: Insulin 
transferrin selenium; b-FGF: basic- 
fibroblast growth factor.
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